期刊
JOURNAL OF DIABETES AND ITS COMPLICATIONS
卷 31, 期 5, 页码 869-873出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jdiacomp.2017.02.009
关键词
Hypoglycemia; Racial differences; Complications; Insulin; Sulfonylureas; Insulin secretagogues
资金
- Agency for Healthcare Research and Quality [R01HS019859]
- NIDDIC [R01DK103721, R01 DK081796, P30DK092924]
- U.S. Food and Drug Administration [BAA-13-00119]
Aims: Seven-year surveillance study (2005-2011) to evaluate race/ethnic differences in the trends in rates of severe hypoglycemia (SH) in a population of insured, at-risk adults with diabetes. Methods: SH events were identified via any primary or principal diagnosis from emergency department or inpatient encounters among African American, Asian, Latino and White adult diabetes patients treated with insulin or secretagogues (Sulfonylureas or Meglitinides), receiving care from integrated healthcare delivery systems across the United States. We calculated age- and sex-standardized annual SH rates and average annual percent change (AAPC) in SH rates. Results: Annual SH rates ranged from 1.8% to 2.1% during this 7-year observation period (2,200,471 person years). African Americans had consistently higher SH rates compared with Whites, while Latinos and Asians had consistently lower rates compared with Whites in each of the 7 years (all p < 0.01). The trend increased significantly only among African Americans (AAPC = +43%; 95% CI: +2.1, +6.5%); in the other groups, the AAPC was not significantly different from zero. Conclusions: Surveillance efforts should monitor the racial/ethnic-specific rates. The factors underlying substantially higher rates of hypoglycemia in African Americans should be evaluated. Clinically and culturally-appropriate strategies to reduce the risk of SH need to be developed and tested. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据